Overall survival (non‐taxane monotherapy vs taxane monotherapy) · advanced gastric adenocarcinoma
Chemotherapy showed no clear difference in overall survival (non‐taxane monotherapy vs taxane monotherapy) compared with chemotherapy (low certainty).
1 finding from 1 review
Overall survival (taxane‐containing doublet therapy vs taxane monotherapy) · advanced gastric adenocarcinoma
Chemotherapy showed no clear difference in overall survival (taxane‐containing doublet therapy vs taxane… compared with chemotherapy (low certainty).
1 finding from 1 review
Overall survival (non‐taxane containing therapy vs another non‐taxane containing therapy) · advanced gastric adenocarcinoma
1 finding from 1 review
Progression‐free survival (PSF) · advanced gastric adenocarcinoma
Chemotherapy showed no clear difference in progression‐free survival (non‐taxane monotherapy vs taxane… compared with chemotherapy (low certainty).
3 findings from 1 review
HR 1.14 [0.88, 1.48]
1 study · 219 participants
Low
HR 0.75 [0.52, 1.09]
2 studies · 121 participants
Low
no estimate extracted
1 study · 107 participants
High
Tumour response · advanced gastric adenocarcinoma
Chemotherapy showed no clear difference in tumour response rate (non‐taxane monotherapy vs taxane monotherapy) compared with chemotherapy (low certainty).
2 findings from 1 review
Tumour response rate (taxane‐containing doublet therapy vs taxane monotherapy) · advanced gastric adenocarcinoma
It is very uncertain whether chemotherapy changes tumour response rate (taxane‐containing doublet therapy vs taxane… compared with chemotherapy (very low certainty).
1 finding from 1 review
Treatment failure (need to restart phototherapy or exchange transfusion or both) · neonatal jaundice
1 finding from 1 review
Participants requiring chemotherapy delays · early triple‐negative breast cancer
Platinum‐containing chemotherapy leads to higher participants requiring chemotherapy delays compared with chemotherapy without platinum (high certainty).
1 finding from 1 review
Smoking cessation · people who smoke
Hypnotherapy showed no clear difference in hypnotherapy versus attention‐matched behavioural treatments Smoking… compared with behavioural treatments or no treatment (low certainty).
4 findings from 1 review
Show 1 more finding
Adverse events (common reactions to aromatherapy include skin rashes, dyspnoea, headache, cardiac arrhythmias, hypotension, hypertension or dizziness) · adults and children having any type of surgical procedure under general anaesthesia, regional anaesthesia or sedation, as hospital…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of SAD (SIGH‐SAD score ≥ 20) ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether light therapy changes incidence of SAD (SIGH‐SAD score ≥ 20) ( compared with no light therapy (very low certainty).
1 finding from 1 review
Incidence of severe SAD (SIGH‐SAD‐SR (≥ 40)) ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether light therapy changes incidence of severe SAD (SIGH‐SAD‐SR (≥ 40)) ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Adverse effects of antibiotics · children, aged 2 to 59 months, with WHO‐defined non‐severe pneumonia and wheeze
Antibiotic therapy showed no clear difference in treatment harms (adverse events or side effects associated with… compared with placebo compared to placebo (low certainty).
1 finding from 1 review
Incidence of SAD (SIGH‐SAD score ≥ 20) ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether infrared light therapy changes incidence of SAD (SIGH‐SAD score ≥ 20) ( compared with no light therapy (very low certainty).
1 finding from 1 review
Incidence of severe SAD (SIGH‐SAD‐SR (≥ 40)) ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether infrared light therapy changes incidence of severe SAD (SIGH‐SAD‐SR (≥ 40)) ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether infrared light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Incidence of SAD (SIGH‐SAD score ≥ 20) ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether bright white light therapy changes incidence of SAD (SIGH‐SAD score ≥ 20) ( compared with no light therapy (very low certainty).
1 finding from 1 review
Incidence of SAD (SIGH‐SAD score ≥ 20) ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether bright white light therapy changes incidence of SAD (SIGH‐SAD score ≥ 20) ( compared with infrared light therapy (very low certainty).
1 finding from 1 review
Incidence of severe SAD (SIGH‐SAD‐SR (≥ 40)) ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether bright white light therapy changes incidence of severe SAD (SIGH‐SAD‐SR (≥ 40)) ( compared with infrared light therapy (very low certainty).
1 finding from 1 review